131 related articles for article (PubMed ID: 11086018)
1. Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.
Khachigian LM
J Clin Invest; 2000 Nov; 106(10):1189-95. PubMed ID: 11086018
[No Abstract] [Full Text] [Related]
2. DNA cuts its teeth--as an enzyme.
Finkel E
Science; 1999 Dec; 286(5449):2441-2. PubMed ID: 10636800
[No Abstract] [Full Text] [Related]
3. New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury.
Santiago FS; Lowe HC; Kavurma MM; Chesterman CN; Baker A; Atkins DG; Khachigian LM
Nat Med; 1999 Nov; 5(11):1264-9. PubMed ID: 10545992
[TBL] [Abstract][Full Text] [Related]
4. Egr-1: is it always immediate and early?
Yan SF; Pinsky DJ; Mackman N; Stern DM
J Clin Invest; 2000 Mar; 105(5):553-4. PubMed ID: 10712422
[No Abstract] [Full Text] [Related]
5. Coating stents with antirestenotic drugs: the blunderbuss or the magic bullet?
Lowe HC; Khachigian LM
Circulation; 2002 Jan; 105(4):E29. PubMed ID: 11815443
[No Abstract] [Full Text] [Related]
6. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
Fahmy RG; Khachigian LM
Nucleic Acids Res; 2004; 32(7):2281-5. PubMed ID: 15107496
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma.
Worden B; Yang XP; Lee TL; Bagain L; Yeh NT; Cohen JG; Van Waes C; Chen Z
Cancer Res; 2005 Aug; 65(16):7071-80. PubMed ID: 16103054
[TBL] [Abstract][Full Text] [Related]
8. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
[TBL] [Abstract][Full Text] [Related]
9. Dinucleotide junction cleavage versatility of 8-17 deoxyribozyme.
Cruz RP; Withers JB; Li Y
Chem Biol; 2004 Jan; 11(1):57-67. PubMed ID: 15112995
[TBL] [Abstract][Full Text] [Related]
10. An efficient RNA-cleaving DNA enzyme that synchronizes catalysis with fluorescence signaling.
Mei SH; Liu Z; Brennan JD; Li Y
J Am Chem Soc; 2003 Jan; 125(2):412-20. PubMed ID: 12517153
[TBL] [Abstract][Full Text] [Related]
11. DNAzymes as molecular agents that manipulate Egr-1 gene expression.
Khachigian LM
Biochem Pharmacol; 2004 Sep; 68(6):1023-5. PubMed ID: 15313396
[TBL] [Abstract][Full Text] [Related]
12. [Catalytic DNA--deoxyribozymes].
Nawrot B
Postepy Biochem; 2002; 48(1):20-33. PubMed ID: 12101522
[No Abstract] [Full Text] [Related]
13. Two-component 10-23 DNA enzymes.
Fokina AA; Kuznetsova MA; Repkova MN; Venyaminova AG
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(6-7):1031-5. PubMed ID: 15560098
[TBL] [Abstract][Full Text] [Related]
14. Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.
Fokina AA; Meschaninova MI; Durfort T; Venyaminova AG; François JC
Biochemistry; 2012 Mar; 51(11):2181-91. PubMed ID: 22352843
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor 2 and the transcription factor Egr-1 localise to endothelial cell microvascular channels in human coronary artery occlusion.
Bhindi R; Brieger D; Ishii H; Di Girolamo N; Kumar RK; Khachigian LM; Lowe HC
Thromb Haemost; 2005 Jan; 93(1):172-4. PubMed ID: 15875316
[No Abstract] [Full Text] [Related]
16. Inhibition of human papillomavirus expression using DNAzymes.
Benítez-Hess ML; Reyes-Gutiérrez P; Alvarez-Salas LM
Methods Mol Biol; 2011; 764():317-35. PubMed ID: 21748650
[TBL] [Abstract][Full Text] [Related]
17. Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application.
Sioud M; Leirdal M
J Mol Biol; 2000 Feb; 296(3):937-47. PubMed ID: 10677293
[TBL] [Abstract][Full Text] [Related]
18. Toward an atomistic model for predicting transcription-factor binding sites.
Endres RG; Schulthess TC; Wingreen NS
Proteins; 2004 Nov; 57(2):262-8. PubMed ID: 15340913
[TBL] [Abstract][Full Text] [Related]
19. Coordinate expression and distinct DNA-binding characteristics of the four EGR-zinc finger proteins in Jurkat T lymphocytes.
Skerka C; Decker EL; Zipfel PF
Immunobiology; 1997 Dec; 198(1-3):179-91. PubMed ID: 9442390
[TBL] [Abstract][Full Text] [Related]
20. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain.
Huang RP; Liu C; Fan Y; Mercola D; Adamson ED
Cancer Res; 1995 Nov; 55(21):5054-62. PubMed ID: 7585551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
